1
|
Franke K, Lüdemann M, Gonzalez Y Gonzalez MB. [Cardiac arrhythmias in adults with congenital heart disease]. Herzschrittmacherther Elektrophysiol 2024:10.1007/s00399-024-01037-7. [PMID: 39225799 DOI: 10.1007/s00399-024-01037-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2024] [Accepted: 07/24/2024] [Indexed: 09/04/2024]
Abstract
In patients with congenital heart disease, cardiac arrhythmias are complex and require a thorough understanding of the anatomy, past surgical and interventional procedures, and the specific electric processes. Supraventricular tachycardias commonly present as emergency situations and should be treated immediately, particularly when there is an underlying complex malformation. Establishing sinus rhythm is usually superior to pure frequency control for hemodynamic reasons. Catheter ablation should be preferred over medical treatment, even though several procedures are often necessary. In addition, bradycardia is seen more frequently in congenital heart defects; this could be aggravated by antiarrhythmic drugs. There are significant differences between the indications and techniques used for pacemaker implantation in patients with congenital heart defects and those without. Patients with complex congenital heart diseases have an increased risk of thromboembolism; therefore, an individual and early indication for low-threshold oral anticoagulation is necessary; direct oral anticoagulants can also be used for this purpose. In risk stratification for sudden cardiac death, the principles of general guidelines are often not applicable, and individualized decisions are required. Recently, a new general risk score for congenital heart disease has been developed. The treatment of cardiac arrhythmias in patients with congenital heart disease should always be performed in close cooperation with specialized centers.
Collapse
Affiliation(s)
- Katharina Franke
- Kinderherzzentrum und Zentrum angeborene Herzfehler, Universitätsklinikum Gießen und Marburg, Standort Gießen, Feulgenstraße 10-12, 35385, Gießen, Deutschland.
| | - Monika Lüdemann
- Kinderherzzentrum und Zentrum angeborene Herzfehler, Universitätsklinikum Gießen und Marburg, Standort Gießen, Feulgenstraße 10-12, 35385, Gießen, Deutschland
| | - Maria B Gonzalez Y Gonzalez
- Kinderherzzentrum und Zentrum angeborene Herzfehler, Universitätsklinikum Gießen und Marburg, Standort Gießen, Feulgenstraße 10-12, 35385, Gießen, Deutschland
| |
Collapse
|
2
|
Alawsi F, Sawbridge D, Fitzgerald R. Orthodontics in patients with significant medical co-morbidities. J Orthod 2020; 47:4-24. [PMID: 32985344 DOI: 10.1177/1465312520949881] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
A wide variety of patients with medical co-morbidities may present to general orthodontic practice. It is important for the treating clinician to have a general understanding of key medical conditions that may impact upon the treatment and management options. This clinical supplement provides a treatment-focused summative update for the orthodontist regarding significant medical co-morbidities, their general prevalence and an exploration of potential impacts upon orthodontic treatment. This review also discusses the significance of key medications and provides suggestions for the safe provision of orthodontic treatment.
Collapse
Affiliation(s)
- Fahad Alawsi
- Orthodontic Department, Royal Preston Hospital, Preston, UK
| | - David Sawbridge
- Intestinal Failure Unit, Salford Royal NHS Foundation Trust, Salford, UK
| | - Rhian Fitzgerald
- Orthodontic Department, Royal Preston Hospital, Preston, UK.,Alder Hey Children's Hospital, Liverpool, UK
| |
Collapse
|
3
|
Ning H, Cui Y, Song X, Chen L, Yin Z, Hua L, Ren F, Suo Y, Wang X, Zhang H, Hu D, Ge Y. iTRAQ-based proteomic analysis reveals key proteins affecting cardiac function in broilers that died of sudden death syndrome. Poult Sci 2020; 98:6472-6482. [PMID: 31509194 PMCID: PMC8913949 DOI: 10.3382/ps/pez532] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2019] [Accepted: 08/31/2019] [Indexed: 12/26/2022] Open
Abstract
Sudden death syndrome (SDS), which is a cardiac-related condition commonly observed in chickens selected for rapid growth, causes significant economic losses to the global poultry industry. Its pathogenesis in broilers is poorly understood, and little is known about the proteome of the heart tissue of SDS broilers. A quantitative proteomic approach using isobaric tags for relative and absolute quantification labeling of peptides was used to characterize the protein expression profiles in the left ventricle of SDS broilers. These proteins were further analyzed by bioinformatics, and two proteins were validated by western blot analysis. We identified 186 differentially expressed proteins (DEPs), of which 72 were upregulated, and 114 were downregulated in the SDS group. Functional annotation suggested that 7 DEPs were related to cardiac muscle contraction, and another 7 DEPs were related to cardiac energy metabolism. Protein interaction network predictions indicated that differences in cardiac muscle contraction between SDS and healthy groups were regulated by troponin T, tropomyosin alpha-1 chain, fast myosin heavy chain HCIII, myosin-1B, coronin, and myoglobin, whereas differences in cardiac energy metabolism and biosynthesis of amino acids were regulated by gamma-enolase, phosphoglycerate mutase, NADH-ubiquinone oxidoreductase chain 2, serine/threonine-protein kinase, myoglobin, and alpha-amylase. Our expression profiles provide useful information and new insights into key proteins to elucidate SDS for further studies.
Collapse
Affiliation(s)
- Hongmei Ning
- College of Animal Science and Technology, Henan Institute of Science and Technology, Xinxiang 453003, China
| | - Yunli Cui
- College of Animal Science and Technology, Henan Institute of Science and Technology, Xinxiang 453003, China
| | - Xiaochao Song
- College of Animal Science and Technology, Henan Institute of Science and Technology, Xinxiang 453003, China
| | - Lingli Chen
- College of Animal Science and Technology, Henan Institute of Science and Technology, Xinxiang 453003, China
| | - Zhihong Yin
- College of Animal Science and Technology, Henan Institute of Science and Technology, Xinxiang 453003, China.,Postdoctoral Research and Development Base, Henan Institute of Science and Technology, Xinxiang 453003, China
| | - Liushuai Hua
- College of Animal Science and Technology, Henan Institute of Science and Technology, Xinxiang 453003, China
| | - Fei Ren
- College of Animal Science and Technology, Henan Institute of Science and Technology, Xinxiang 453003, China
| | - Yu Suo
- College of Animal Science and Technology, Henan Institute of Science and Technology, Xinxiang 453003, China
| | - Xinrui Wang
- College of Animal Science and Technology, Henan Institute of Science and Technology, Xinxiang 453003, China
| | - Hongli Zhang
- College of Animal Science and Technology, Henan Institute of Science and Technology, Xinxiang 453003, China
| | - Dongfang Hu
- College of Animal Science and Technology, Henan Institute of Science and Technology, Xinxiang 453003, China.,Postdoctoral Research and Development Base, Henan Institute of Science and Technology, Xinxiang 453003, China
| | - Yaming Ge
- College of Animal Science and Technology, Henan Institute of Science and Technology, Xinxiang 453003, China
| |
Collapse
|